The U.S. Diabetes Prevention Program (DPP) recently released findings from a 21-year follow-up study, showcasing the long-term impact of intensive lifestyle interventions and metformin in reducing the development of diabetes. The study revealed that the original intensive lifestyle intervention led to a 24% reduction in diabetes development, while metformin reduced it by 17%.
Initially, the DPP study demonstrated that after three years, the intensive lifestyle intervention focusing on weight loss and increased physical activity, as well as the medication metformin, significantly lowered the onset of type 2 diabetes compared to a placebo. The follow-up study included 3,195 participants and was published in the Lancet Diabetes and Endocrinology journal.
The research highlighted that both the lifestyle intervention and metformin had long-lasting benefits in preventing diabetes development. Participants who were part of the original trial experienced an extended period without diabetes, with the lifestyle group gaining an extra 3.5 years and the metformin group gaining 2.5 years compared to the placebo group.
The DPP study, which began in 1996 with participants aged around 51 years, included a significant representation of U.S. minority groups vulnerable to type 2 diabetes. The positive effects of the interventions were observed across all racial and ethnic groups involved in the study.
The results emphasize that the substantial effects seen in the initial years of the trial translated into sustained reductions in diabetes development over two decades, increasing the number of years lived without diabetes. Despite the challenges of maintaining long-term lifestyle changes and medication use, the study underscores the enduring benefits of even short-term interventions.
At present, the DPP/DPPOS site at Pennington Biomedical Research Center continues to follow 76 residents in Baton Rouge who have been part of the study for over 26 years. Dr. Owen Carmichael, the current site leader, praised the dedication of the participants and acknowledged their contribution to advancing medical knowledge and improving global health outcomes.
The study was led by William C. Knowler and published in The Lancet Diabetes & Endocrinology. The findings underscore the importance of lifestyle modifications and medication use in preventing the onset of type 2 diabetes over the long term.
This research was conducted in collaboration with Louisiana State University, underscoring the significant impact of local communities in driving advancements in healthcare. The study participants from Louisiana have played a crucial role in shaping modern medicine and contributing to the well-being of populations worldwide.
